title: Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.
authors.affiliation: Department of Neurology, Washington University in St Louis, Saint Louis, MO 63110, USA. cliffordd@neuro.wustl.edu
authors.forename: David B
authors.initials: DB
authors.lastname: Clifford
authors.forename: Andrea
authors.initials: A
authors.lastname: De Luca
authors.forename: Andrea
authors.initials: A
authors.lastname: DeLuca
authors.forename: David M
authors.initials: DM
authors.lastname: Simpson
authors.forename: Gabriele
authors.initials: G
authors.lastname: Arendt
authors.forename: Gavin
authors.initials: G
authors.lastname: Giovannoni
authors.forename: Avindra
authors.initials: A
authors.lastname: Nath
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D007968:Leukoencephalopathy, Progressive Multifocal / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000069442:Natalizumab